Browsing Tag

Faricimab

1 post
FDA Approves Faricimab for nAMD and Diabetic Macular Edema thumbnail

FDA Approves Faricimab for nAMD and Diabetic Macular Edema

The US Food and Drug Administration (FDA) today approved faricimab (Vabysmo, Genentech/Roche) to treat diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Compared with antivascular endothelial growth factor (VEGF) drugs currently in use, faricimab requires fewer intravitreal injections on average, so it may reduce the burden on both patients and their physicians while…
Read More
Index Of News